The effect of folic acid on plasma homocysteine and main cardiovascular events for patients with hyperhomocysteinima-related hypertention

XU Zhong-lin; ZHAO Yi-fa; WU Lan-lan

doi:10.13406/j.cnki.cyxb.2011.06.011

您当前的位置：

首页 >

文章列表页 >

The effect of folic acid on plasma homocysteine and main cardiovascular events for patients with hyperhomocysteinima-related hypertention

更新时间：2024-01-17

- The effect of folic acid on plasma homocysteine and main cardiovascular events for patients with hyperhomocysteinima-related hypertention
- Journal of Chongqing Medical University Vol. 36, Issue 6, Pages: 731-733(2011)
- 作者机构：
  
  重庆市第九人民医院心内科
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2011.06.011
  CLC： R544.1
- Published：2011，
扫描看全文
[1]徐中林,赵义发,吴兰兰.叶酸对H型高血压同型半胱氨酸水平和主要心血管事件的影响[J].重庆医科大学学报,2011,36(06):731-733.

XU Zhong-lin, ZHAO Yi-fa, WU Lan-lan. The effect of folic acid on plasma homocysteine and main cardiovascular events for patients with hyperhomocysteinima-related hypertention. [J]. Journal of Chongqing Medical University 36(6):731-733(2011)
[1]徐中林,赵义发,吴兰兰.叶酸对H型高血压同型半胱氨酸水平和主要心血管事件的影响[J].重庆医科大学学报,2011,36(06):731-733. DOI： 10.13406/j.cnki.cyxb.2011.06.011.

XU Zhong-lin, ZHAO Yi-fa, WU Lan-lan. The effect of folic acid on plasma homocysteine and main cardiovascular events for patients with hyperhomocysteinima-related hypertention. [J]. Journal of Chongqing Medical University 36(6):731-733(2011) DOI： 10.13406/j.cnki.cyxb.2011.06.011.

摘要

目的:探讨叶酸干预治疗对H型高血压患者血浆同型半胱氨酸（Homocysteine

Hcy）水平和主要心血管事件（非致死性心肌梗塞、脑梗塞及心血管疾病死亡）的影响。方法:将264例高血压合并高Hcy的H型高血压患者随机分为试验组124例和对照组140例

试验组和对照组均强调生活方式的改变和正规药物降压等常规治疗

试验组在常规治疗的基础上同时给予口服叶酸5 mg qd。随访3个月后两组患者血浆Hcy水平的变化和整个随访期间两组无主要心血管事件生存率情况。结果:与治疗前及对照组相比

试验组叶酸治疗3个月后血浆Hcy水平显著下降（P<0.05）

而对照组无明显变化。整个随访期间对照组无主要心血管事件生存率为85%

试验组为93.5%

2组间差异有统计学意义（P<0.05）。结论:叶酸干预治疗可以明显降低H型高血压患者血浆Hcy水平并增加无主要心血管事件生存率。

Abstract

Objective:To evaluate the effect of folic acid on plasma homocysteine and main cardiovascular events in patients with hyperhomocysteinima-related hypertention.Methods:264 patients with hyperhomocysteinima-related hypertention were randomly divided into two groups.All patients in the two groups were given the routine treatment with antihypertensive drug.124 patients in the treatment group were given oral folic acid(5 mg/d)in addition to routine treatment.Results:The plasma homocysteine in treatment group was reduced significantly compared with that ofpretreatment and control group after folic acid administration for 3 months(P<0.05).The survival rates of none cardiovascular events was 85% in control group and 93.5% in treatment group(P<0.05).Conclusion:The treatment of oral folic acid reduces the level of plasma homocysteine and increases the survival rates of none cardiovascular events in patients with hyperhomocysteinima-related hypertention.

关键词

叶酸H型高血压同型半胱氨酸心血管事件

Keywords

folic acidhyperhomocysteinima-related hypertentionhomocysteinemain cardiovascular events

references

Views

1097

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The mechanism of Bu-Yang-Huan-Wu decoction in treating acute cerebral infarction by evaluating the levels of serum procalcitonin and homocysteine

Clinical value of plasma Cys C,Hcy,sICAM-1 for early detection of diabetic nephropathy

Effects of hormone replacement therapy to lipid in postmenopausal women: A systemic review

An investigation on mechanism of the TLR4/NF-κB on Hcy to promote the damage of HUVECs

Relationship between level of cerebrospinal fluid homocysteine and cognitive dysfunction in patients with Parkinson’s disease

Related Author

Heng Wang

Tingting Li

Chenghui Wang

Fan Gong

Jianli Ni

Jun Wang

Weidong Pan

Pang Wei

Related Institution

Department of Traditional Chinese Medicine，Chongming Branch of Xinhua Hospital，Shanghai Jiao Tong University School of Medicine

Department of Encephalopathy，Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Diabetes Mellitus,the First Affiliated Hospital of Kunming Medical University

School of Public Health and Management,Center for Research of Medicine and Social Development,the Innovation Center for Social Risk Governance in Health,Chongqing Medical University

Department of Biochemistry,Inspection Institute,Ningxia Medical University

⁰